Terumo India has announced the launch of FineCross M3 Coronary Micro-Guide Catheter in India. This catheter for percutaneous coronary intervention (PCI), offer enhanced crossing ability, guidewire support, and navigability in complex lesions that often hamper procedural success.
Commenting on the launch Shishir Agarwal, President and Managing Director, Terumo India said, “Innovation at Terumo India is always guided by enabling physicians to deliver the best possible care to patients. With the launch of FineCross M3, we are proud to bring a globally trusted advancement in interventional cardiology to India. This milestone reflects not only our commitment to strengthening cardiovascular care in the country, but also Our Promise “Unwavering commitment to patients” that lies at the heart of everything we do.”
Key features include 1.7 Fr tapered distal tip for superior lesion crossability, 15 cm floppy distal segment for exceptional trackability through tortuous vessels, tapered stainless-steel braided shaft for enhanced pushability and control, next-generation hydrophilic coating for unmatched lubrication and durability and PTFE inner layer with radiopaque marker for smooth device delivery and precise visualisation.
Adding perspective on the product’s clinical relevance, Nitin Stephen Abel, Senior Director, Terumo Interventional Systems, Terumo India said, “FineCross M3 represents more than just a product launch, it reflects our continued focus on advancing cardiovascular care in India in line with Terumo’s mission of contributing to society through healthcare. Through globally trusted innovations, we aim to empower physicians in delivering better patient outcomes and create a meaningful impact where it matters most.”